News | July 04, 2007

Medipattern, HealthCareIQ Team Up to Support Reimbursement Process for B-CAD

July 5, 2007 - Medipattern Corp., developer of computer-aided diagnosis (CAD) solutions for breast ultrasound imaging, announced a strategic alliance with HealthcareIQ LLC, reaching an agreement where Medipattern’s clients will have access to payer-specific benefit plan rules, coding guidelines and medical necessity protocols.

To date, the alliance has benefited Medipattern’s clients through both claims submission support and the successful receipt of reimbursements for the reporting of findings used to evaluate and manage patient care and provide diagnostic indicators that substantiate evidenced-based medicine, all obtained through use of B-CAD. Nationally recognized healthcare insurance companies are paying for the supervision of the B-CAD evaluation and management procedure for reporting and review by radiologists.

“B-CAD is a procedure performed on outpatients using breast ultrasound images and as such is reimbursable under the American Medical Associations (AMA) Common Procedure Terminology (CPT) code guidelines for evaluation and management procedures,” said Arthur Gelber, president and CEO of HealthcareIQ.

“B-CAD includes an automated workflow that naturally follows the radiologists’ process for correctly classifying lesions into corresponding American College of Radiology (ACR) Breast Imaging Reporting And Data System (BI-RADS) terminology, which forms the basis for evidence-based reporting and compliance with not only the ACR but payers’ guidelines for appropriate billing and reporting requirements. B-CAD’s ability to convert the details captured during the review of ultrasound breast images in a natural language report helps reduce the need for transcription as well as providing a comprehensive record for physicians to track patient progress as they manage the patients’ care. Breast care clinics need to be able to track subtle changes over the course of years to provide adequate patient care. B-CAD uses the ACR BI-RADS lexicon for evaluation of lesions and its structured reporting provides the necessary framework for evidence of tracking care over the long term,” stated Jeff Collins, CEO of The Medipattern Corporation.

For more information: www.medipattern.com

Related Content

FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
King's College London and NVIDIA Build U.K.'s First AI Platform for NHS Hospitals

King's College London will implement NVIDIA DGX-2 systems for AI research in the first phase of the project.

News | Artificial Intelligence | May 13, 2019
NVIDIA and King’s College London announced they are partnering to build an artificial intelligence (AI) platform that...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.  
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad Companion Chest CT,...
Telerad Tech Launches MammoAssist AI Software
Technology | Computer-Aided Detection Software | January 25, 2019
Telerad Tech recently announced the launch of MammoAssist, a new artificial intelligence (AI) product to analyze and...